Source: Global Legal Chronicle

Rodin Therapeutics: Alkermes plc's Acquisition Of Rodin Therapeutics, Inc.

WilmerHale LLP acted ad legal advisor to Alkermes plc. Goodwin Procter LLP represented Rodin Therapeutics, Inc. Alkermes plc announced the completion of its previously announced acquisition of Rodin Therapeutics, Inc., a privately held biopharmaceutical company focused on developing novel, small molecule therapeutics for synaptopathies. Under the terms of the definitive agreement, and subject to the [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Adam J. Rosenberg's photo - President & CEO of Rodin Therapeutics

President & CEO

Adam J. Rosenberg

CEO Approval Rating

86/100

Read more